Strong first quarter 2023: Sales of Exyte increases by a third year-on year to 2.0 billion euros
Significant sales increase by 33,6% to €2.0 billion year-on-yearSubstantial growth of adjusted EBIT and adjusted EBITDA of around 19% to €113 million and €125 million, respectivelyOrder intake